Literature DB >> 6106010

The chemotherapy of amoebiasis.

R Knight.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6106010     DOI: 10.1093/jac/6.5.577

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  22 in total

1.  Amoebic psoas and liver abscesses.

Authors:  C O'Leary; R Finch
Journal:  Postgrad Med J       Date:  1992-12       Impact factor: 2.401

Review 2.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya.

Authors:  H O Pamba; B B Estambale; C N Chunge; L Donno
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.

Authors:  J A Upcroft; R W Campbell; K Benakli; P Upcroft; P Vanelle
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

5.  Antiamoebic and toxicity studies of a carbamic acid derivative and its therapeutic effect in a hamster model of hepatic amoebiasis.

Authors:  Cynthia Ordaz-Pichardo; Mineko Shibayama; Saúl Villa-Treviño; Myriam Arriaga-Alba; Enrique Angeles; Mireya de la Garza
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

6.  Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections.

Authors:  Nader S Abutaleb; Mohamed N Seleem
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

Review 7.  Drug targets and mechanisms of resistance in the anaerobic protozoa.

Authors:  P Upcroft; J A Upcroft
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 8.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Caerulomycin, an antifungal antibiotic with marked in vitro and in vivo activity against Entamoeba histolytica.

Authors:  D K Chatterjee; W Raether; N Iyer; B N Ganguli
Journal:  Z Parasitenkd       Date:  1984

10.  Bond-based linear indices in QSAR: computational discovery of novel anti-trichomonal compounds.

Authors:  Yovani Marrero-Ponce; Alfredo Meneses-Marcel; Oscar M Rivera-Borroto; Ramón García-Domenech; Jesus Vicente De Julián-Ortiz; Alina Montero; José Antonio Escario; Alicia Gómez Barrio; David Montero Pereira; Juan José Nogal; Ricardo Grau; Francisco Torrens; Christian Vogel; Vicente J Arán
Journal:  J Comput Aided Mol Des       Date:  2008-05-16       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.